Envisia Therapeutics envisiatherapeutics.com


Public list: Smart Money VCs (6328) Pharma Startups (4733)

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit dise...Show all

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT platform to develop t...Show all

Company (Alive / Active)

Phone: 919-973-1440

Fax:

419 Davis Drive
Suite 100
Morrisville, 27560
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Envisia Therapeutics $46.1M Mar 17, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Envisia Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
New Enterprise AssociatesVenture CapitalMenlo Park, California, United StatesSeries A - II, Series A
Canaan PartnersVenture CapitalMenlo Park, California, United StatesSeries A - II, Series A
Morningside Group (晨兴集团)Private EquityCauseway Bay, Hong KongSeries A
Morningside Group (晨兴集团)Private EquityCauseway Bay, Hong KongSeries A
Pappas VenturesVenture CapitalDurham, North Carolina, United StatesSeries A
Undisclosed InvestorsOtherConvertible Note
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Intracameral implant for treatment of an ocular condition Dec 05, 2014 Application